| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 411 |
| 1 | ACETAMINOPHEN | 350 |
| 2 | PREDNISONE | 338 |
| 3 | METHYLPREDNISOLONE | 309 |
| 4 | FUROSEMIDE | 280 |
| 5 | ASPIRIN | 275 |
| 6 | ASPIRIN 325 MG | 268 |
| 7 | ASPIRIN 81 MG | 268 |
| 8 | AMLODIPINE | 255 |
| 9 | DIPHENHYDRAMINE HYDROCHLORIDE | 247 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-BVZR | 15 | 0.0213 |
| 1 | DIFLUNISAL | 15 | 0.0185 |
| 2 | SPARSENTAN | 115 | 0.0170 |
| 3 | CASPOFUNGIN ACETATE | 24 | 0.0151 |
| 4 | SIBEPRENLIMAB | 10 | 0.0145 |
| 5 | NUSINERSEN | 110 | 0.0139 |
| 6 | ADEFOVIR DIPIVOXIL | 14 | 0.0110 |
| 7 | ALPROSTADIL | 30 | 0.0083 |
| 8 | BEVACIZUMAB-AWWB | 38 | 0.0081 |
| 9 | PASIREOTIDE | 18 | 0.0080 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 711 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 623 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 471 |
| 3 | Loop Diuretic [EPC] | 333 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 332 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 300 |
| 6 | Benzodiazepine [EPC] | 297 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 282 |
| 8 | Kinase Inhibitor [EPC] | 281 |
| 9 | Calcium Channel Blocker [EPC] | 256 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antisense Oligonucleotide [EPC] | 126 | 0.0105 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 144 | 0.0074 |
| 2 | Provitamin D2 Compound [EPC] | 202 | 0.0068 |
| 3 | Osmotic Diuretic [EPC] | 29 | 0.0056 |
| 4 | Adrenocorticotropic Hormone [EPC] | 4 | 0.0045 |
| 5 | Ergot Derivative [EPC] | 20 | 0.0041 |
| 6 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 7 | Reducing and Complexing Thiol [EPC] | 8 | 0.0032 |
| 8 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 10 | 0.0030 |
| 9 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 17 | 0.0027 |